Therefore, the present experiments were designed to test the hypothesis that histamine H2-receptor antagonism reduces arterial blood pressure in vivo and improves endothelial function, as studied ex vivo, in angiotensin II–induced hypertension in the mouse. This evidence concerns the gene HRH2 and hypertensive disorder.